Combined effects of genetic polymorphisms of P-selectin and P-selectin glycoprotein ligand-1 on the binding of platelets to monocytes

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages 475-477

  Panzer, Simon ^a   Stegfellner, Michael ^a   Jungbauer, Lea ^a   Ay, Cihan ^a   Kaider, Alexandra ^a   Mannhalter, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN;

ADULT; AGED; CELL INTERACTION; CELL SURFACE; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LETTER; LIGAND BINDING; MALE; MONOCYTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ADHESION;

ADULT; BLOOD PLATELETS; CELLS, CULTURED; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; P-SELECTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOEMBOLISM;

EID: 77951666222     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.10.007     Document Type: Letter

References (21)

1. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., and Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-Selectin. Studies in baboons, human coronary intervention, and human Acute myocardial infarction. Circulation 104 (2001) 1533-1537
2. Zimmerman G.A. Two by two: The pairings of P-selectin and P-selectin glycoprotein ligand 1. Proc Natl Acad Sci U S A 98 (2001) 10023-10024
3. Dole V.S., Bergmeier W., Patten I.S., Hirahashi J., Mayadas T.N., and Wagner D.D. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost 98 (2007) 806-812
4. Engelmann B., Luther T., and Müller I. Intravascular tissue factor pathway: a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 89 (2003) 3-8
5. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 (2003) 1585-1598
6. Lösche W., Scholz T., Temmler U., Oberle V., and Claus R.A. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 15 (2004) 109-115
7. Panes O., Matus V., Sáez C.G., Quiroga T., Pereira J., and Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 109 (2007) 5242-5250
8. Lozano M.L., González-Conejero R., Corral J., Rivera J., Iniesta J.A., Martinez C., et al. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Br J Haematol 115 (2001) 969-976
9. Tregouet D.A., Barbaux S., Escolano S., Tahri N., Golmard J.L., Tiret L., et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11 (2002) 2015-2023
10. Tregouet D.A., Barbaux S., Poirier O., Blankenberg S., Bickel C., Escolano S., et al. SELPLG gene polymorphisms in relation to plasma SELPLG levels and coronary artery disease. Ann Hum Genet 67 (2003) 504-511
11. Bugert P., Vosberg M., Entelmann M., Jahn J., Katus H.A., and Klüter H. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin Chem Lab Med 42 (2004) 997-1004
12. Bugert P., Pabinger I., Stamer K., Vormittag R., Skeate R.C., Wahi M.M., et al. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154. Thromb Haemost 97 (2007) 573-580
13. Ay C., Jungbauer L.V., Sailer T., Tengler T., Koder S., Kaider A., et al. High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. Clin Chem 53 (2007) 1235-1243
14. Ay C., Jungbauer L.V., Kaider A., Koder S., Panzer S., Pabinger I., et al. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Thromb Haemost 99 (2008) 899-904
15. Volcik K.A., Ballantyne C.M., Coresh J., Folsom A.R., and Boerwinkle E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 195 (2007) e76-e82
16. Panzer S., Rosales S., Gisslinger H., Jungbauer L., Kaider A., Knöbl P., et al. Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism. Thromb Res 121 (2008) 573-579
17. Panzer S., Höcker L., and Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 85 (2006) 121-125
18. Rosin C., Brunner M., Lehr S., Quehenberger P., and Panzer S. The formation of platelet-leukocyte aggregates varies during the menstrual cycle. Platelets 17 (2006) 61-66
19. Moore K.L., Patel K.D., Bruehl R.E., Li F., Johnson D.A., Lichenstein H.S., et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 128 (1995) 661-671
20. Patel K.D., Nollert M.U., and McEver R.P. P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J Cell Biol 131 (1995) 1893-1902
21. Ruchaud-Sparagano M.H., Malaud E., Gayet O., Chignier E., Buckland R., and McGregor J.L. Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis. Biochem J 332 (1998) 309-314